Record title
A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab
Record identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4fb7dc79948645e3bc27099ba6ae06b0
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4fb7dc79948645e3bc27099ba6ae06b0
Share
A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab
About this item
Full title
A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Clinical and translational science, 2022, Vol.15 (3), p.626-637
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4fb7dc79948645e3bc27099ba6ae06b0
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4fb7dc79948645e3bc27099ba6ae06b0
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4fb7dc79948645e3bc27099ba6ae06b0
Other Identifiers
ISSN
E-ISSN
DOI
